Stunnenberg, Bas C <br/><br/>
Guidelines on clinical presentation and management of nondystrophic myotonias.  [electronic resource] 

 -  Muscle & nerve  10 2020 
 - 430-444 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1097-4598 
<br/><br/><label>Standard No.: </label>10.1002/mus.26887  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetazolamide--therapeutic use<br/>Age of Onset<br/>Carbonic Anhydrase Inhibitors--therapeutic use<br/>Chloride Channels--genetics<br/>Electrodiagnosis<br/>Electromyography<br/>Fatigue--physiopathology<br/>Genetic Testing<br/>Humans<br/>Lamotrigine--therapeutic use<br/>Mexiletine--therapeutic use<br/>Muscle Weakness--physiopathology<br/>Muscle, Skeletal--physiopathology<br/>Myalgia--physiopathology<br/>Myotonia Congenita--drug therapy<br/>Myotonic Disorders--genetics<br/>NAV1.4 Voltage-Gated Sodium Channel--genetics<br/>Practice Guidelines as Topic<br/>Ranolazine--therapeutic use<br/>Sodium Channel Blockers--therapeutic use<br/>Voltage-Gated Sodium Channel Blockers--therapeutic use